Mailer 'Misleads' About Cancer Drug's Efficacy: FDA
The U.S. Food and Drug Administration told Takeda Pharmaceutical Co. unit Millennium Pharmaceuticals Inc. that a mailer about the billion-dollar cancer drug Velcade was false and misleading because it overstated the...To view the full article, register now.
Already a subscriber? Click here to view full article